SPBC1198.07c Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPBC1198.07c; Putative mannan endo-1,6-alpha-mannosidase C1198.07c; Endo-alpha-1->6-D-mannanase C1198.07c
Target Names
SPBC1198.07c
Uniprot No.

Target Background

Database Links
Protein Families
Glycosyl hydrolase 76 family
Subcellular Location
Endoplasmic reticulum membrane; Single-pass type I membrane protein.

Q&A

What is SPBC1198.07c and how is its antibody typically generated?

SPBC1198.07c is a systematic identifier for a gene in the fission yeast Schizosaccharomyces pombe. Based on genomic databases, this gene encodes a protein that researchers may study using antibody-based detection methods. Antibodies against S. pombe proteins like SPBC1198.07c are typically generated through several approaches:

  • Recombinant protein expression in E. coli, followed by purification and immunization

  • Synthetic peptide generation representing specific epitopes of the SPBC1198.07c protein

  • Genetic tagging approaches (such as TAP-tagging) as observed in similar S. pombe studies

For optimal antibody generation, researchers often select immunogenic regions that are accessible in the native protein conformation and avoid transmembrane domains. The antibody production process typically involves animal immunization (commonly rabbits for polyclonal or mice for monoclonal antibodies), followed by serum collection and antibody purification .

What are the standard validation methods for SPBC1198.07c antibody?

Validation of SPBC1198.07c antibody specificity is critical for reliable experimental results. Standard validation approaches include:

  • Western blot analysis using wild-type strains and SPBC1198.07c deletion mutants (similar to the upf1Δ approach shown in the materials)

  • Immunoprecipitation followed by mass spectrometry to confirm target protein identity

  • Immunofluorescence microscopy comparing signal between wild-type and knockout strains

  • Using epitope-tagged versions of SPBC1198.07c (such as TAP-tagged constructs) as positive controls

When validating the antibody, researchers should observe a band of the predicted molecular weight in wild-type samples that is absent in deletion mutants. Cross-reactivity with other proteins should be minimal to ensure experimental specificity. For TAP-tagged validation approaches, methods similar to those used for Upf1:TAP protein detection with PAP antibodies would be applicable .

What sample preparation methods are optimal for SPBC1198.07c detection?

Effective sample preparation is crucial for detecting SPBC1198.07c in S. pombe. Based on established protocols for similar yeast proteins:

  • Cell growth and harvesting should follow standard techniques for S. pombe culture, using appropriate media such as YES rich media

  • Cell lysis protocols should be optimized to preserve protein integrity, typically using glass bead disruption in appropriate buffer systems

  • Extraction methods should consider the subcellular localization of SPBC1198.07c (nuclear, cytoplasmic, membrane-associated)

  • Protease inhibitors should be included to prevent protein degradation during sample preparation

For total protein extraction, protocols similar to those described for detecting Upf1:TAP protein would be appropriate, ensuring complete cell disruption while maintaining native protein structure. The culture media should be prepared using de-ionized water and standard sterilization procedures to maintain consistency across experiments .

How should I design appropriate controls for SPBC1198.07c antibody experiments?

Robust controls are essential for antibody-based experiments involving SPBC1198.07c:

  • Positive controls: Wild-type S. pombe strains expressing SPBC1198.07c at normal levels

  • Negative controls: SPBC1198.07c deletion mutants (similar to the upf1::kanMX6 strain construction)

  • Specificity controls: Pre-immune serum or isotype-matched control antibodies

  • Loading controls: Detection of constitutively expressed proteins like Act1 (actin)

  • Tagged controls: Strains expressing tagged versions of SPBC1198.07c

The experimental design should include side-by-side analysis of these controls to validate antibody specificity. For example, when conducting Western blot analysis, samples from wild-type and deletion strains should be run on the same gel to directly compare band patterns. Additionally, competitive binding assays using purified antigen can further confirm antibody specificity .

What are the optimal Western blotting conditions for SPBC1198.07c antibody?

Western blotting using SPBC1198.07c antibody requires optimization of several parameters:

  • Sample preparation: Total cell extracts should be prepared using established protocols for S. pombe

  • Protein loading: 20-50 μg of total protein per lane is typically sufficient

  • Gel percentage: Select based on the molecular weight of SPBC1198.07c (10-12% for 30-100 kDa proteins)

  • Transfer conditions: Semi-dry or wet transfer at appropriate voltage/amperage

  • Blocking solution: 5% non-fat dry milk or BSA in TBST (Tris-buffered saline with 0.1% Tween-20)

  • Antibody dilution: Start with 1:1000 and optimize based on signal-to-noise ratio

  • Incubation time: Typically overnight at 4°C for primary antibody

  • Detection method: HRP-conjugated secondary antibodies with chemiluminescent substrates

The protocol should include appropriate controls and may require optimization of antibody concentration and incubation conditions to maximize specific signal while minimizing background. Detection methods similar to those used for Upf1:TAP protein would be appropriate for visualizing SPBC1198.07c .

What strategies are effective for troubleshooting weak or non-specific SPBC1198.07c antibody signals?

When encountering issues with SPBC1198.07c antibody performance, systematic troubleshooting approaches include:

ProblemPotential CausesTroubleshooting Strategies
Weak signalLow antibody concentrationIncrease antibody concentration or incubation time
Low protein expressionIncrease sample loading or enrich target protein
Inefficient transferOptimize transfer conditions or membrane type
High backgroundNon-specific bindingIncrease blocking time/concentration or change blocking agent
Secondary antibody cross-reactivityUse more specific secondary antibody or increase washing steps
Contaminated antibodyUse fresh antibody aliquot or purified fraction
Multiple bandsProtein degradationAdd more protease inhibitors during extraction
Post-translational modificationsConfirm with phosphatase treatment or genetic variants
Cross-reactivityPerform antigen competition or use knockout controls

When troubleshooting, make single changes to the protocol at a time and maintain careful documentation of all modifications and their effects on experimental outcomes .

How can SPBC1198.07c antibody be used to investigate protein-protein interactions?

SPBC1198.07c antibody can be employed in several techniques to identify and characterize protein-protein interactions:

  • Co-immunoprecipitation (Co-IP): Using SPBC1198.07c antibody to pull down the protein and associated binding partners

  • Proximity ligation assay (PLA): Detecting in situ interactions between SPBC1198.07c and candidate binding partners

  • Bimolecular fluorescence complementation (BiFC): Similar to the VN-VC fragment approach mentioned in search result

  • Chromatin immunoprecipitation (ChIP): If SPBC1198.07c has DNA-binding properties or associates with chromatin

For Co-IP experiments, protocols should be optimized to preserve native protein complexes, using appropriate lysis buffers and conditions. The approach used for studying Cuf2 and Mei4 interaction through plasmids like pJK-500cuf2+-VN and pBPnmt1+3X-mei4+-VC could serve as a model for investigating SPBC1198.07c interactions .

What approaches are recommended for using SPBC1198.07c antibody in immunofluorescence microscopy?

For successful immunofluorescence microscopy with SPBC1198.07c antibody:

  • Fixation method: Typically 3.7% formaldehyde for 30 minutes, though optimization may be required

  • Permeabilization: Enzymatic digestion of cell wall (using zymolyase) followed by detergent treatment

  • Blocking solution: BSA or normal serum from the species of secondary antibody origin

  • Antibody dilution: Start with 1:100 and optimize based on signal intensity

  • Counterstaining: DAPI for nuclear visualization and cell wall staining for cell morphology

  • Mounting medium: Anti-fade reagent to prevent photobleaching

The protocol should include appropriate controls, including cells lacking SPBC1198.07c expression. For accurate subcellular localization, co-staining with markers of specific cellular compartments may be necessary. Flow cytometry approaches similar to those used for detecting PD-1 in the research described in search result could be adapted for S. pombe cells expressing SPBC1198.07c .

How can SPBC1198.07c antibody be used in chromatin immunoprecipitation (ChIP) studies?

If SPBC1198.07c functions as a transcription factor or chromatin-associated protein, ChIP protocols can be adapted:

  • Crosslinking: Typically with 1% formaldehyde for 15-20 minutes

  • Chromatin shearing: Sonication to generate 200-500 bp fragments

  • Immunoprecipitation: Using optimized amounts of SPBC1198.07c antibody

  • Washing conditions: Stringent washes to remove non-specific binding

  • Elution and reversal of crosslinks: Typically at 65°C overnight

  • DNA purification and analysis: qPCR, sequencing, or microarray analysis

For analyzing DNA binding sites, primers can be designed to amplify potential regulatory regions similar to the approach used for studying FLEX elements in the fzr1+ promoter region. ChIP protocols should include appropriate controls such as input chromatin, no-antibody controls, and immunoprecipitation with irrelevant antibodies .

How should I analyze Western blot data generated using SPBC1198.07c antibody?

Quantitative analysis of Western blot data requires a structured approach:

  • Image acquisition: Use a digital imaging system with a linear dynamic range

  • Background subtraction: Apply consistent background correction across all samples

  • Normalization: Normalize to loading controls (e.g., actin) or total protein

  • Quantification: Measure integrated density of specific bands

  • Statistical analysis: Apply appropriate statistical tests for comparing multiple conditions

When analyzing expression changes, consider biological and technical replicates (minimum of three each). For publication-quality data, verify that measurements fall within the linear range of detection and report both raw and normalized values. Similar to RNA analysis approaches described for act1+ mRNA as a control in the research, stable reference proteins should be used for normalization in protein expression studies .

How can I reconcile contradictory results between antibody-based detection and genetic approaches for SPBC1198.07c?

When facing conflicting data between different experimental approaches:

  • Validate reagents: Confirm antibody specificity and genetic construct integrity

  • Consider protein modifications: Post-translational modifications may affect antibody recognition

  • Evaluate expression levels: Overexpression or knockdown efficiency may vary

  • Assess genetic compensation: Related genes may compensate in knockout studies

  • Examine experimental conditions: Different growth conditions may affect results

It may be useful to employ multiple, complementary approaches to study SPBC1198.07c function. For example, combining gene deletion studies with antibody-based protein detection, similar to the approach used for studying upf1 mutants in the search results. When reporting contradictory results, clearly document all experimental conditions and consider alternative hypotheses that might explain the discrepancies .

What bioinformatic resources can help interpret SPBC1198.07c antibody-based experimental results?

Several bioinformatic tools and databases can aid in interpreting SPBC1198.07c antibody results:

  • PomBase: The primary genomic database for S. pombe, providing gene annotation and functional information

  • UniProt: Protein sequence and functional information

  • InterPro: Protein domain and family analysis

  • STRING: Protein-protein interaction networks

  • GO Term Analysis: Functional categorization of genes and proteins

  • S. pombe expression databases: Transcriptomic profiles under different conditions

These resources can provide context for antibody-based findings, suggesting potential functions, interaction partners, and regulatory mechanisms for SPBC1198.07c. Integrating experimental data with bioinformatic analysis can lead to more comprehensive understanding of the protein's biological role, similar to the approach used in characterizing Upf1 targets in S. pombe .

How can SPBC1198.07c antibody be used to study protein expression during stress conditions?

Investigating SPBC1198.07c expression during stress conditions requires careful experimental design:

  • Stress exposure protocols: Define appropriate stressors (e.g., oxidative stress with hydrogen peroxide as mentioned in the viability assays)

  • Time course analysis: Monitor expression changes at multiple time points

  • Dose-response relationships: Examine expression changes at various stress intensities

  • Subcellular localization: Assess potential changes in protein localization during stress

  • Stability assessment: Determine if protein stability is affected by stress conditions

When designing these experiments, include appropriate controls and consider both acute and chronic stress exposures. The viability assays approach described for hydrogen peroxide exposure (ranging from 0.25-4 mM) in YES rich media could serve as a model for studying SPBC1198.07c expression under oxidative stress conditions .

What approaches are recommended for studying SPBC1198.07c during the cell cycle?

To investigate cell cycle-dependent regulation of SPBC1198.07c:

  • Synchronization methods: Use nitrogen starvation, hydroxyurea block, or temperature-sensitive cdc mutants

  • Time-point collection: Sample at regular intervals covering at least one complete cell cycle

  • Cell cycle markers: Co-stain for established cell cycle phase markers

  • Flow cytometry: Combine with DNA content analysis to correlate with cell cycle phase

  • Live cell imaging: For dynamic changes in protein localization during cell division

Experimental design should include careful validation of synchronization efficiency and use multiple synchronization methods to rule out method-specific artifacts. The preparation and synchronization techniques described for pat1-114/pat1-114 diploid cells could be adapted for studying SPBC1198.07c expression during meiosis or the mitotic cell cycle .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.